Patents Assigned to Sorenson Pharmaceutical, Inc.
  • Patent number: 5972317
    Abstract: A nail-permeable medication means is disclosed for delivering a medicament through nails, claws, hoofs, or other similar hardened tissue of dermal derivation. The nail-permeable medication means includes a proteolytic enzyme component which facilitates permeation of substances through the hardened nail or keratin tissue, and also includes a medicament component selected to treat a specific disease. The nail-permeable medication means is particularly useful for treating onychomycosis of the fingernail or toenail, and avoids the need for more drastic therapeutic modalities, such as removal of the nail.
    Type: Grant
    Filed: August 6, 1998
    Date of Patent: October 26, 1999
    Assignee: Sorenson Pharmaceutical, Inc.
    Inventors: James L. Sorenson, Robert V. Petersen
  • Patent number: 5840283
    Abstract: A nail-permeable medication means is disclosed for delivering a medicament through nails, claws, hoofs, or other similar hardened tissue of dermal derivation. The nail-permeable medication means includes a proteolytic enzyme component which facilitates permeation of substances through the hardened nail or keratin tissue, and also includes a medicament component selected to treat a specific disease. The nail-permeable medication means is particularly useful for treating onychomycosis of the fingernail or toenail, and avoids the need for more drastic therapeutic modalities, such as removal of the nail.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: November 24, 1998
    Assignee: Sorenson Pharmaceutical, Inc.
    Inventors: James L. Sorenson, Robert V. Petersen